SKVI
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company offers sunless tanning and sunscreen products under the Skinbrella name. It also licenses to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.05 | $5,000 | — |
| 2025 Q4 | -0.05 | $5,000 | -$38.4B |
| 2025 Q3 | -0.05 | $5,000 | $4,611 |
| 2025 Q2 | -0.05 | $5,000 | -$9,189 |
| 2025 Q1 | -0.05 | $5,000 | -$31,720 |
| 2024 Q4 | 0.06 | $5,000 | -$16,912 |
| 2024 Q3 | -0.06 | $5,000 | -$12,542 |
| 2024 Q2 | -0.07 | $5,000 | -$37,307 |